Skip to Content


In the US, Adriamycin (doxorubicin systemic) is a member of the drug class antibiotics/antineoplastics and is used to treat Acute Lymphoblastic Leukemia, Acute Myeloblastic Leukemia, Bladder Cancer, Breast Cancer, Bronchogenic Carcinoma, Cancer, Diffuse Large B-Cell Lymphoma, Hodgkin's Lymphoma, Lymphoma, Multiple Myeloma, Neuroblastoma, Osteosarcoma, Ovarian Cancer, Soft Tissue Sarcoma, Stomach Cancer, Thyroid Cancer and Wilms' Tumor.

US matches:

Ingredient matches for Adriamycin


Doxorubicin is reported as an ingredient of Adriamycin in the following countries:

  • Egypt

Doxorubicin hydrochloride (a derivative of Doxorubicin) is reported as an ingredient of Adriamycin in the following countries:

  • Australia
  • Canada
  • China
  • Denmark
  • Finland
  • Iceland
  • Kenya
  • New Zealand
  • Norway
  • United States

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.